[1]
Gill, H.K. et al. 2025. RESPONSE TO PAMIDRONATE THERAPY AND PHARMACOGENETICS IN PATIENTS WITH OSTEOGENESIS IMPERFECTA. Journal of the ASEAN Federation of Endocrine Societies. 40, S1 (May 2025), 136. DOI:https://doi.org/10.15605/jafes.040.S1.228.